Intracranial haemorrhage in premature neonates - Epidemiology and prevention

Citation
Ja. Thorp et al., Intracranial haemorrhage in premature neonates - Epidemiology and prevention, CNS DRUGS, 11(6), 1999, pp. 421-433
Citations number
68
Categorie Soggetti
Pharmacology,"Neurosciences & Behavoir
Journal title
CNS DRUGS
ISSN journal
11727047 → ACNP
Volume
11
Issue
6
Year of publication
1999
Pages
421 - 433
Database
ISI
SICI code
1172-7047(199906)11:6<421:IHIPN->2.0.ZU;2-J
Abstract
Prematurity is the most important risk factor for intracranial haemorrhage (ICH). Many aetiological factors contribute to ICH in neonates, including t rauma with labour, mode of delivery, acidemia, hypoxia, hypercarbia, immatu rity of the coagulation system, change in newborn blood pressure, and newbo rn stress from resuscitation. Antenatal initiatives to prevent ICH have foc used on advancing gestational age, pharmacological interventions, optimisin g acid-base status and limiting intrapartum trauma. Neonatal initiatives ha ve focused on pharmacological and supportive measures which stabilise cereb ral blood now and oxygen delivery by local and systemic actions. The potent ial for pharmacological agents which could reduce capillary bleeding or act as antioxidiants to further prevent ICH remain a pressing research need.